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The present study was performed to investigate the efficacy and safety of Ultrasound-targeted microbubble 
destruction (UTMD) mediated rAAV2-EGFP to cultured human retinal pigment epithelium (RPE) cells in 
vitro and the rat retina in vivo. In vitro study, cultured human RPE cells were exposed to US under different 
conditions with or without microbubbles. Furthermore, the effect of UTMD to rAAV2-EGFP itself and the 
cells were evaluated. In vivo study, gene transfer was examined by injecting rAAV2-EGFP into the 
subretinal space of the rats with or without microbubbles and then exposed to US. We investigated EGFP 
expression in vivo via stereomicroscopy and performed quantitative analysis by Axiovision 3.1 software. 
HE staining and frozen sections were used to observe tissue damage and location of EGFP gene expression. 
In vitro study, the transfection efficiency of rAAV2-EGFP increased 74.85% under the optimal UTMD 
conditions. Furthermore, there was almost no cytotoxicity to the cells and rAAV2-EGFP itself. In vivo 
study, UTMD could be used safely to enhance and accelerate transgene expression of the retina. 
Fluorescence expression was mainly located in the layer of retina. UTMD is a promising method for gene 
delivery to the retina. 
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Introduction 
Many inherited and acquired retinal diseases have become the leading causes of blindness in adults and 
RPE cells are believed to be involved in the pathogenesis of some such diseases, such as retinitis 
pigmentosa (RP), Leber Congenital Amaurosis (LCA), and proliferative vitreoretinopathy (PVR).1,2 
Currently, there is no satisfactory treatment available for these disorders. Gene therapy represents a 
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promising therapeutic option for these diseases. One of the most critical areas of gene therapy is the design 
of an appropriate, accurate, and effective gene transfer system that can be safely applied in vivo. 
Adeno-associated virus (AAV) vectors have a number of important advantages over other vectors which 
make them suitable for transfection studies, in particular the ability to induce long-term transgene 
expression in the eye and a relative lack of pathogenicity.1,3,4 However, the transduction of AAV occurs 
with relatively low efficiency which limits its therapeutic effects. Maybe increasing AAV transduction 
could produce better therapeutic effects.5-7  
 
UTMD has been proved to enhance gene transfer in various studies in vitro and in vivo. UTMD could serve 
as a potential site-specific gene transfer modality, but the mechanism is not definite. Sonoporation which 
can transiently enhance the permeability of cell membranes to introduce genes into cells by exposing them 
to ultrasound is considered to play a key role, and microbubbles acted as cavitation nuclei can effectively 
focus ultrasound energy and further potentiate bioeffects. 8-11 Recent reports show that Ultrasound (US) / 
Microbubbles (MBs) can be used safely and efficiently in many models of diseases in various organs.12 As 
far as we know, in the sphere of ophthalmology, scholars pay much attention to studying 
ultrasound-mediated transfection (USMT) or ultrasound-targeted microbubble destruction (UTMD) on the 
cornea,13-17 but few reports on the retina. Moreover, ultrasound/ microbubbles mediated transduction 
mainly focuses on plasmid-DNA, few reports have been published about ultrasound/ microbubbles and 
AAV. Thus we got the idea that since UTMD could greatly increase plasmid-DNA transfer to the corneal 




In vitro study 
1. Gene transfer by ultrasound alone 
The US intensities and the exposure time were set at 1 W/cm2, 2 W/cm2, 3 W/cm2, 60s and 120s 
respectively (50% duty cycle). There was no difference between the US exposure groups and the control 
group (P>0.05, Figure 1A). 
 
2. Gene transfer by microbubbles alone 
The ratios of MBs to cells we selected for our study were 40:1 and 50:1. There was no difference between 
the groups in which the cells were treated with microbubbles alone and the control group (P>0.05, Figure 
1B). 
 
3. Gene transfer by ultrasound and microbubbles  
To identify the optimal conditions to transfer rAAV2-EGFP by ultrasound with microbubbles, the following 
four parameters were examined. 
 
3.1 Pulse wave and continuous wave 
Pulse wave and continuous wave were examined under an intensity of 2 W/cm2 for 60s with microbubbles 
(the ratio of MBs to cells as 50:1). Three duty cycles (10%, 20%, 50%) of pulse wave and continuous wave 
were studied. As a result, the ratios of the EGFP-positive cells were 17.68% of the control group, 17.53%, 
25.77%, 30.43% with 10%, 20%, 50% duty cycle respectively and 33.67% with continuous wave. Under 
the condition of 50% duty cycle, UTMD could significantly enhance the transfection efficiency (Figure 2A, 
P<0.05). Although UTMD could significantly enhance the transfection efficiency under the condition of 
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continuous wave (P<0.001), the cell viability was lower than 85.0% (Figure 2C).  
 
3.2 Microbubbles 
Five ratios of MBs to cells (20:1, 30:1, 40:1, 50:1, 60:1) were examined under the US condition of 1 W/cm2, 
60s, and 50% duty cycle. The increased percentage of transfection efficiency in 50:1 group was 
significantly than that in 20:1, 30:1 and 40:1 groups (P<0.05, Figure 3A). There was no difference between 
the ratios of 50:1and 60:1 (P>0.05). 
 
3.3 US Intensity and Exposure Time 
The US intensities of 1 W/cm2, 2 W/cm2, 3 W/cm2 and the exposure time of 60s and 120s were examined 
(50% duty cycle and the ratio of MBs to cells as 50:1). The ratio of EGFP-positive cells in the UTMD 
(US+MBs) group was significantly higher than that of the corresponding USMT (US) group (P<0.01, 
Figure 3B). In the UTMD group, there was no difference between the 1 W/cm2, 60s and other conditions 
(P>0.05, Figure 3B). Moreover, under the condition of 1 W/cm2 and 60s, little cell damage was observed 
by Trypan Blue assay.  
 
4. The effect of UTMD to rAAV2-EGFP  
The effect of UTMD to rAAV2-EGFP itself was evaluated by the transfection efficiency of the cells after 
UTMD. There was no difference between the experimental groups (power, 1 W/cm2 and 3 W/cm2; 50% 
duty cycle; 60s and 120s; the ratio of MBs to cells as 50:1) and the control group (P>0.05, Figure 4). 
5. Cell viability assay 
We performed Trypan Blue assay immediately after UTMD with various exposure parameters to measure 
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the cytotoxicity of the cells. Under the condition of 1 W/cm2, 2 W/cm2, 3 W/cm2, 50% duty cycle, 120s, the 
ratio of MBs to cells as 50:1, the cell viability decreased in sequence. Under the condition of 3W/cm2, 120s, 
and 60:1, the cell viability decreased to 58.67% (Figure 5). 
 
In vivo study 
1. The number of EGFP positive rats on the 4th day: The number of EGFP positive rats of Group 4 was 
significantly more than that of other groups (P<0.05, Table 1). 
2.  EGFP expressions of four groups at different time points. The quantity of fluorescence in Group 4, in 
which AAV was combined with ultrasound and microbubbles, was significantly higher than that in 
other three groups on the 4th, 7th and 35th day. There was no difference for the longer days. EGFP 
expression increased from the 7th to the 35th day, and fell from the 49th to the 120th day (Figure 6). 
3. Tissue stretched preparation on the 35th day. The number of transfected cells in Group 4 (Figure 7B) 
was more than that in Group 1 (Figure 7A) and EGFP expression mainly showed in RPE cells (Figure 
7C). 
4. Histology showed no evident tissue damage after UTMD mediated AAV transfection (Figure 8). 
5. The frozen section of fundus oculi showed that EGFP expression mainly appeared in the layer of 
retina (Figure 9). 
 
Table 1 The number of EGFP positive rats on the fourth day  
Group/ Number Group1          Group 2           Group 3          Group 4   
Number of EGFP positive rats      5               4                5                  10 
Number of observed rats          12              12               11                  11 
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Gene therapy can potentially correct inherited and acquired diseases of the retina. The retina has structure 
and accessibility properties which make it an ideal target organ for genetic therapies. Moreover, in the last 
two decades, over 130 genes have been identified to cause retinal diseases and many animal models also 
have been built.1,3,18-21 Recently, the potential for gene delivery to the eye using AAV vectors has received 
much attention.1,3,4 However, the transfection of AAV occurs with relatively low efficiency and later 
expression in some tissues, which limits its therapeutic effects. Several methods to increase the transfection 
efficiency of AAV vectors have been explored, such as combinational use with adenovirus or drug of 
chemotherapy,6 However, the above strategies have many limitations. We used sodium butyrate combined 
with rAAV2-EGFP to transfect human RPE cells in vitro. We achieved higher transfection efficiency, but 
higher cell death rate (data not shown). A new and improved method of delivery system is required to 
augment the efficiency of AAV infection. 
 
Ultrasound/microbubbles associated local gene therapy has potential for not only plasmid-DNA, but also 
virus-mediated gene transfer, just like adenovirus, adeno-associated virus, retroviral.22-27 Ralph V. Shohet et 
al demonstrated successful transfection of rat myocardium in vivo by UTMD of microbubbles containing 
an adenovirus encoding a beta-galactosidase reporter gene.23 Transfection efficiencies by ultrasound with 
retrovirus were enhanced 6.6-fold, 4.8-fold, 2.3-fold, and 3.2-fold in 293T cells, BAECs, RASMCs, and L6 
cells, respectively.25 Recent research outcomes showed that UTMD could augment cardiac transfection of 
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AAV vectors after intravenous administration in rats. UTMD significantly increased cardiac reporter 
activities 6-20 fold compared with control rats which received the same amount of virus without 
microbubbles, but with ultrasound.22 
 
Our findings indicated that UTMD could exert a significant enhancing effect on rAAV2-mediated gene 
expression in RPE cells. To establish the optimal conditions of UTMD mediated gene transfer to human 
RPE cells, various US conditions were examined. First, the duty cycle of US was evaluated. Results clearly 
showed that a continuous wave was most effective to transfer genes, but cell damage was severe. Duty 
cycles of 10% and 20% provided almost identical gene transfer efficiency. A duty cycle of 50% increased 
transfection efficiency significantly. Therefore, a duty cycle of 50% was chosen for our purpose. Second, 
the ratio of MBs to cells was evaluated. A ratio of 20:1 could not make the gene transfer efficiently and the 
ratios of 30:1and 40:1 provided almost identical gene transfer efficiency. There was no difference between 
the ratios of 50:1and 60:1. Thus, 50:1 was chosen. Third, US power and exposure time were studied. 
Comprehensively considering gene transfer efficiency and cellular damage, an US power of 1W/cm2 was 
chosen, and exposure time was set at 60s. Finally, rAAV2-EGFP transfection efficiency after UTMD was 
evaluated. There was no difference between the exposure groups at varying power levels (1w/cm2, 60s; 
3w/cm2, 60s; 1w/cm2, 120s; 3w/cm2, 120s) and the control group. That is to say UTMD had no apparent 
effect to rAAV2-EGFP transfection efficiency. The ratios of EGFP-positive cells in the above exposure 
groups were lower than that of the control group, because there were some viruses losing when we 
transferred them from the exposure well to the wells with cells.  
 
Our studies showed that AAV combined with microbubbles without ultrasound or with ultrasound exposure 
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alone could not increase the transfection efficiency, but UTMD could increase rAAV2 transfer to human 
RPE cells in vitro. The optimal parameters were as follows: power, 1 W/cm2; duration, 60s; duty cycle, 
50%; the ratio of MBs to cells as 50:1. Under this condition, UTMD increased the transfection efficiency 
about 74.85%，and the cell viability was above 95%. Furthermore, there was almost no cytotoxicity to 
rAAV2-EGFP itself.  
 
Our previous study used methyl thiazolyl tetrazolium (MTT) assay to measure human RPE proliferation 
after UTMD for 24 hours and 72 hours.28,29 In this study, we used Trypan Blue assay to measure the cell 
viability immediately after UTMD. The optimal parameters combination we filtrated was safe (The cell 
viability was higher than 95%) not only immediately but also 24 and 72 hours later after UTMD. Our team 
members achieved the similar trends of UTMD mediated rAAV2-EGFP transfection in human renal 
carcinoma cells in vitro and demonstrated that UTMD mediated gene delivery occurred principally via 
enhancing gene entry rather than the transcriptional level or DNA replication (data not shown). Much of 
reports showed that USMT could enhance gene transfer efficiency, but in our study, USMT did nothing 
effective to human RPE cells. Maybe higher energy was needed for transient pore of human RPE cells. 
 
In vivo study, scholars pay much attention to studying USMT on the cornea. In the beginning, they focused 
on drug delivery.14 Recently, gene delivery of the cornea has been studied. There was a study showed that 
using US in conjunction with commercially available MBs could enhance gene delivery to the cornea 
without damaging tissues.16 Saito K et al found that the degree of cell injury induced by ultrasound scaled 
with exposure intensity and duration.17 Our previous study showed that ultrasound combined with Sonovue 
could increase plasmid transfer to the mouse cornea in vivo safely.30  
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In our preliminary experiment in vivo, we used different grouping of power (1 w/cm2, 2 w/cm2, 3 w/cm2) 
and MBs (1, 2μl) with duration of 5 minutes. We selected 2w/cm2 and 1μl MBs as our experimental 
conditions. Just like our study in vitro, USMT and MBs alone did nothing effective to the transfection 
efficiency of the retina in vivo. UTMD could make rAAV2-mediated EGFP express earlier after injection 
and substantially increase gene expression before the fastigium (35days). The difference was smaller 
gradually along with the time prolonging. Although the transfection efficiency of Group 4 was higher than 
that of other groups, there was no difference between them after 35days. The mechanism by which US 
enhanced gene delivery was thought to be linked to sonoporation, and UTMD could intensify the bioeffect 
of sonoporation. Sonoporation provided another way for AAV entering the cells, and the transient pores 
appeared immediately after US exposure, so AAV entered the cells by UTMD earlier and much more than 
by natural infection. The fact that UTMD enhanced rAAV2-mediated gene expression in the live retina was 
further confirmed by fluorescent stereoscope imaging of the rat retina and fluorescence quantitative 
methods by Axiovision 3.1 software. Integrated optical density (IOD) values showed that UTMD (Group 4) 
enhanced expression levels about 82.12%, 44.58%, 27.1% and 21.9% on the 4th, 35th, 49th and 120th day 
respectively compared with natural infection (Group 1). These data strongly suggested the potential utility 
of UTMD for improving expression levels of r AAV2-mediated gene transfer in the retina in vivo.  
 
In our study, EGFP expression trends of  the four groups were similar to previous reports.31,32 Frozen 
sections of fundus oculi showed EGFP expression major in the layer of retina. The hexagonal shapes of the 
fluorescent cells were clearly identified at high magnification (×400), suggesting that the majority of the 
transfected cells were RPE cells. This was similar to previous reports. 31,32 
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The novelty of our study was that our report described the first successful demonstration that UTMD could 
be used not only to enhance, but also to accelerate transgene expression of the retina. UTMD provided a 
new way for systemic administration of AAV vectors. 
 
In this study, we approved that UTMD could enhance AAV transfection efficiency in human RPE cells in 
vitro and Wistar rat retina in vivo. How to enhance the transfection efficiency furthest and how to maximize 
the amount of AAV that can be attached to MBs are worthy to be studied in future. We only evaluated the 
tissue structure damage of the retina, further evaluation of vision threaten is much more important, 
especially for eventual clinical application. 
 
Materials and methods 
In vitro study  
Cell Culture 
ARPE-19 (human retinal pigmented epithelium) cell line was obtained from American Type Culture 
Collection (CRL-2302™, ATCC, Rockville, Maryland, USA) and the cells were incubated in Dulbecco’s 
modified Eagle’s medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum in a 
37 °C, 5% CO2/95% air according environment. Human RPE cells were put into 24-well plates every other 
well at 2×105 cells/well prior to infection. 
 
Virus  
The type 2 recombinant adeno-associated viral vectors encoding enhanced green fluorescent protein gene   
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(rAAV2-CMV-EGFP) was purchased from Vector Gene Technology Company Limited (Beijing, China). 
MBs  
SonoVue (Bracco, Milan, Italy), a lipid-shelled US contrast agent filled with sulfur hexafluoride gas, is 
composed of about 2×108 /ml microbubbles, having an average diameter of 2.5–6.0 μm. 
 
Ultrasound Exposure Protocol 
A therapeutic ultrasound machine (Topteam161, Chattanooga, America) was used. The area of the probe 
was 25 mm2. The cells were exposed to ultrasound (frequency, 1 MHz; power, 1 W/cm2, 2 W/cm2, 3W/cm2; 
duration, 60 and 120seconds; pulse wave with 10%, 20%, 50% duty cycle and continuous wave; pulse 
recurrent frequency, 100Hz) with or without MBs. The dosage of SonoVue was selected according to the 
ratio of MBs to cells (20:1-60:1). The ultrasound transducer was placed on the bottom of the plates with a 
small amount of coupling medium on the surface of the probe. A self-made plastic disc with a hole in the 
middle was placed between the transducer and the bottom of the plates. The purpose of using the self-made 
plastic disc was to avoid interaction among the radiated wells as well as to ensure the same thickness of 
coupling medium between the probe and the plate. The DMEM volume per well was 150μl when exposed 
to US. To attach rAAV2-EGFP to microbubbles sufficiently, rAAV2-EGFP was mixed with microbubbles 
in equivalent volume, and the mixture was incubated at room temperature for 5 minutes to allow an 
electrostatic attachment. Then the mixed solution was added to the plates and exposed to US as described. 2 
hours after infection, the plates were supplemented with DMEM to final volume 500μl. 12 hours after 
infection, the previous DMEM was replaced by fresh DMEM.  
 
Gene transfer efficiency 
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48 hours after transfection, EGFP expression was observed and photographed via inverted fluorescence 
microscopy (ZEISS Axiovert S 100, Jena, Germany). The ratio of the infected cells was examined by 
FACS (EPICS XL, Beckman Coulter Company, Miami, FL, USA).  
 
Cell viability assay 
We performed Trypan Blue assay immediately after UTMD with various exposure parameters to measure 
the cytotoxicity of the cells. The cells were then analyzed to determine the proportion of positive blue 
stained cells through microscopy. 
 
The effect of UTMD to rAAV2-EGFP  
The effect of UTMD to rAAV2-EGFP itself was evaluated by the transfection efficiency to the cells after 
UTMD. After 150μl medium containing rAAV2-EGFP only was exposed to varying conditions (power, 1 
W/cm2 and 3 W/cm2; 50% duty cycle; 60s and 120s; the ratio of MBs to cells as 50:1), the cells were 
transfected by the medium and then the transfection efficiency was evaluated. 
 
In vivo study  
Animal preparation 
Normal adult Wistar rats (180–200g) were used in this experiment. All animals were treated, maintained, 
and sacrificed in accordance with the policies stated in the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research and the guidelines approved by national and local institutions. The rats 
were anesthetized with intraperitoneal injection of 10% chloral hydrate. Pupillary dilatation was achieved 
by using Tropicamide eyedrops. The eyes were gently protruded by a plastic circle and subsequently 
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covered with Ofloxacin Eye Ointemnt. A 26 gauge needle was inserted 1 mm posterior to the corneal 
limbus causing a self-sealing wound tunnel under surgical microscopy (SM-2000J, Shanghai, China). 
Trans-sclera subretinal injection of 3μl viral suspension was made by introducing a micro-injector through 
the sclera and vitreous into subretinal space. The eyes of rats were injected with 3μl rAAV2-EGFP alone or 
combined with 1μl microbubbles or 1μl normal saline (NS). The doses of viral vectors were 3×109 vg /eye.  
 
Animal grouping 
78 rats were used in this study. The rats were divided into 4 groups as follows: 
Group 1: AAV and NS without microbubbles and ultrasound exposure 
Group 2: AAV and MBs without ultrasound exposure 
Group 3: AAV and NS with ultrasound exposure but without microbubbles  
Group 4: AAV and MBs with ultrasound exposure (experimental group) 
In each group, at least 5 rats survived for more than 4 months. Group 4 was the experimental target and the 
remaining groups served as controls. Due to the risk of an overload of volume, we administered the 
infusions (4μl) slowly. 
 
Ultrasound Exposure Protocol 
Right after subretinal injection, the eyes of Group 3 and Group 4 were exposed to ultrasound. The 
frequency was 1MHz, US power was 2w/cm2 and the pulse repetition frequency was 100Hz with 50% duty 




The presence of fluorescence signaling in the in vivo gene expression was determined by direct 
stereomicroscopy (ZEISS, Stemi SV11, Jena, German) on the 4th, 7th, 35th, 49th, and 120th day after gene 
transfer. We investigated the onset of EGFP gene expression, lightness of fluorescence, area of fluorescence 
and its distribution in the fundus in vivo. The number of EGFP positive rats on the 4th day was evaluated by 
two masked observers. The value of gene transfer was quantified through EGFP fluorescence quantitative 
methods by Axiovision 3.1 software. IOD = eye area (μm2) × mean fluorescence intensity (grey). 
 
Histology 
Four eyes under US exposure (2w/cm2, 1μl microbubbles, 5 minutes) were obtained by overdose 
intraperitoneal injection of 10% chloral hydrade to four rats on the 4th day after subretinal injection. The 
sections were stained with hematoxylin and eosin to observe retinal architecture by microscopy (ZEISS, 
Axioplan 2 Imaging, Jena, Germany). All the specimens were observed by two masked observers who 
received no information about the specimens. 
 
Tissue stretched preparation of fundus oculi 
Two eyes were harvested from each group on the 35th day. We visualized the transfected tissue by inverted 
fluorescent microscopy on flat fundus oculi. Fundus oculi were prepared after enucleation of the globe by 
removing the anterior segment with a blade and carefully transferring the whole fundus oculi to a 
microscope slide. Six relieving incisions were made to allow the retina to be flattened. The tissue was 
sealed with glycerin. 
 
Frozen sections of eyeballs 
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Two eyes were harvested from each group on the 35th day postinjection. The enucleated eyes were 
embedded in O.C.T. compound (Sakura, America) and cryosections (10 μm) were cut by cryotome (Leica, 
CM3050S, Germany). We observed the cryosections by fluorescence microscopy (ZEISS, Axioplan 2 
Imaging, Jena, Germany).  
 
Statistical Analysis 
All values were expressed as means and standard deviations (mean ± SD). ANOVA test was used to 
determine the significance of the differences in multiple comparisons. Chi-Square Test was used to 
determine the significance of the measurement data. A value of P<0.05 was considered to be statistically 
significant. The software packages used were SPSS, version 13 (SPSS 13.0, Chicago). 
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Figure 1 Gene transfer by ultrasound or microbubbles alone. (A) There was no difference between the 
control group and the ultrasound exposure groups (P>0.05). (B) There was no difference between the 
control group and the microbubbles groups (P>0.05). 
 
Figure 2 The ratios of EGFP-positive cells under pulse wave and continuous wave (the ratio of MBs to 
cells as 50:1). (A) Under the condition of 50% duty cycle, UTMD could significantly enhance the 
transfection efficiency (P<0.05). (C) Apparent cell damage was found in many cells (arrows) and the 
distribution of cells was sparse under the condition of 2w/cm2 and continuous wave. 
 
Figure 3 Gene transfer by US and MBs under different conditions. (A) The increased percentage of 
transfection efficiency in 50:1 group was significantly higher than that in 20:1, 30:1 and 40:1 groups 
(P<0.05). (B) The ratios of EGFP-positive cells in UTMD (US+MBs) group was significantly higher than 
that of USMT (US) group (P<0.01). In UTMD group, there was no difference between the 1 W/cm2, 60s 
group and other groups (P>0.05). 
 
Figure 4 The effect of UTMD to rAAV2-EGFP itself . There was no difference between the experimental 
groups and the control group (P>0.05). 
 
Figure 5 Cell damage under different US intensities and exposure time. With the increase of irradiation 
intensity, the cell viability decreased gradually. 
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Figure 6 (A) rAAV2-EGFP expression after subretinal injection on the 4th, 7th and 35th day by direct 
fluorescence stereomicroscopy ×25. rAAV2-EGFP expression of Group 4 was visible on the 4th day after 
subretinal injection, and there was no rAAV2- EGFP expression in other groups. (B) EGFP expression 
increased from the 7th to the 35th day, and fell from the 49th day to the 120th day. (C) EGFP expression of 
the fourth Group 4 was significantly higher than that of other three groups on the 4th, 7th and 35th day 
(P<0.05), and there was no difference between Group 4 and other groups on the 49th and 120th day 
(P>0.05). 
 
Figure 7 The density of EGFP positive cells in tissue stretched preparation on the 35th day. The number of 
transfected cells in Group 4 (B) was more than that in Group 1 (A). EGFP expression mainly showed in 
RPE cells (C). 
 
Figure 8 Histology showed no evident tissue damage after UTMD mediated AAV transfection. 
 
Figure 9 Frozen sections of fundus oculi showed EGFP expression major in the layer of retina. 









